Thomas Herzog Selected Research

Thomas Herzog Research Topics

9	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 12/2004
8	Neoplasms (Cancer) 04/2024 - 08/2013
2	Ovarian Epithelial Carcinoma 12/2022 - 12/2016
2	Carcinoma (Carcinomatosis) 08/2013 - 12/2003
1	Endometrial Neoplasms (Endometrial Cancer) 04/2024
1	Female Genital Diseases 01/2023
1	Placenta Previa 08/2021
1	Hemorrhage 08/2021
1	Placenta Accreta 08/2021
1	Cysts 08/2020
1	Endometriosis 08/2020
1	Vaginal Fistula 08/2020
1	Purpura 08/2019
1	Perivascular Epithelioid Cell Neoplasms 08/2019
1	Disseminated Intravascular Coagulation 08/2019
1	Fallopian Tube Neoplasms 01/2017
1	Adenomyosis 05/2014
1	Hypersensitivity (Allergy) 06/2013
1	Meningeal Carcinomatosis 09/2012
1	Anorexia Nervosa 05/2009

2	Biomarkers (Surrogate Marker)IBA 04/2024 - 12/2022
2	PlatinumIBA 04/2024 - 01/2023
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	selinexorIBA 04/2024
1	Bevacizumab (Avastin)FDA Link 01/2023
1	VaccinesIBA 01/2022
1	FurinIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	atezolizumabIBA 01/2022
1	Ethanol (Ethyl Alcohol)IBA 08/2020
1	Hormones (Hormone)IBA 08/2019
1	Dacarbazine (DIC)FDA LinkGeneric 08/2019
1	MTOR InhibitorsIBA 08/2019
1	DNA (Deoxyribonucleic Acid)IBA 02/2018
1	Notch2 ReceptorIBA 08/2013
1	CytokinesIBA 06/2013
1	Interleukin-4 (Interleukin 4)IBA 06/2013
1	Interleukin-13IBA 06/2013
1	Interleukin-5 (Interleukin 5)IBA 06/2013
1	Immunoglobulin E (IgE)IBA 06/2013
1	Topotecan (Hycamtin)FDA LinkGeneric 12/2004

8	Therapeutics 04/2024 - 12/2003
6	Drug Therapy (Chemotherapy) 01/2023 - 09/2012
4	Hysterectomy 08/2021 - 05/2014
1	Immunotherapy 04/2024
1	Salpingo-oophorectomy 08/2020
1	Sclerotherapy 08/2020
1	Drug Tapering 01/2017
1	Activities of Daily Living (ADL) 01/2017
1	Combined Modality Therapy 05/2009
1	Salvage Therapy 12/2004